Research and innovation



To achieve our goal of excellence and be an innovative competitor in our markets,  we are constantly striving to improve the services we offer to our customers.  By listening to their requirements and technological advances, we can develop tools and services adapted to meet the challenges of tomorrow.

The culture of innovation within Staphyt promotes the continuous improvement of our employees’ working comfort, performance,  productivity and responsiveness.



Each year Staphyt invests 10% of its turn-over to maintain a high level of performance in all services. Our experts are involved in national and international working groups and so actively take part to both methodology and regulation reflection and evolution.

In partnership with public and academic institutes, we innovate in setting up new evaluation methods for plant protection and nutrition products.


Staphyt joins the public-private “Research – Development – Innovation” consortium on biocontrol
17 September 2021

Last June, Staphyt’s application to join the Biocontrôle Consortium was selected and we are proud…

+ Read more

Last June, Staphyt’s application to join the Biocontrôle Consortium was selected and we are proud and happy to be increasingly involved in the development of biocontrols.

This consortium, bringing together nearly 60 public research actors, institutes and private developers of innovative solutions, was created in 2020 as part of the French national strategy for the deployment of biocontrol, co-led by the Ministry of Agriculture and of Food and by the Ministry of Ecological Transition. Its mission is to support and promote biocontrol through research and innovation, by creating new tools for monitoring the performance and efficacy of these products. The development of biocontrol solutions requires a better understanding of their mode of action in various agronomic contexts.

In France, biocontrol solutions represent more than 12% of the plant protection market. The Biocontrôle Consortium is one of the tools enabling IBMA France to achieve its ambition: by 2023 to increase the share of this sector to 15% of the French crop protection market and to 30% in France. horizon 2030.

Our technical and scientific teams will participate in discussions and working groups to develop new research themes and deepen existing knowledge on biocontrol products.

For any questions about this ambitious project, do not hesitate to contact Frédéric GIRAUD, Staphyt representative within the consortium.

More information:

On 8 April, ANSES published new documents concerning the marketing of Fertilisers and Growing Media (Matières Fertilisantes et Supports de Culture, MFSC) in connection with the implementation of the Order of 1 April 2020 setting the composition of application dossiers for marketing authorisations and permits for fertilisers, fertiliser adjuvants and growing media and the criteria to be taken into account in the preparation of the elements required for the evaluation. This category of products includes in particular biostimulant products in France.

Newly published documents can be downloaded here. They include :

  • The Cerfa 16073*01 form (PDF and word) replacing the Cerfa 11385 form
  • The explanatory leaflet N°52317#01 to fill in the Cerfa 16073*01 form
  • The Guide related to dossier evaluation
  • The general note related to the submission of MFSC dossiers

A specific note on how to submit dossiers during the confinement period is also available. The possibility of submitting dossiers electronically is one of the measures taken by ANSES.

The most important changes compared to the previous guidance documents concern :

  • The adaptation of the Cerfa form to all types of applications and products.
  • The formal possibility of submitting MFSC dossiers electronically and indication of the nomenclature of the dossiers.
  • The removal of product characterisation analysis when submitting an application for authorisation by mutual recognition.
  • The addition of a consumer risk assessment as part of an AMM application.
  • The need for studies to determine the EC50 of the product as part of an AMM application.

In order to allow applicants to implement these new provisions, ANSES is accepting the submission of applications under the previous provisions until 8 July 2020.

Staphyt has already implemented the necessary actions to submit applications in compliance with these new requirements.

Contact us for support:

Our Research Tax Credit agreement for France has just been renewed and it’s valid for 2020, 2021, 2022, 2023 and 2024. This certificate allows our clients to obtain tax reductions for the studies they contract to Staphyt, which reduces their costs. Staphyt also has agreements in Spain, Italy, Germany, Poland and UK.

See all our agreements.

Staphyt is carefully following the recommendations of the World Health Organization and national health authorities with the view of protecting our employees and our clients, in the face of the global health crisis facing us today.

Please be assured that we are taking all necessary steps to ensure the safe continuity of our services in a constantly evolving situation. Preventative measures have been implemented in all our stations, laboratories and regulatory offices. Employees in all countries are following national guidelines relating to minimising risk (travel/meetings/hygiene), as well as national and Staphyt protocols regarding raising concerns and reporting problems.

Our Agrosciences clients can continue to follow the progress of their projects via our platform Phytnet in the usual way – and both our Regulatory Affairs and Agrosciences teams can be reached as normal by telephone and email.
The World Health Organisation advice for the general public can be found here.

We are monitoring events closely day by day and maintaining real-time close communications with clients’ operational teams to quickly adapt to their needs.
Our teams remain at your service.

Please contact us if you need our help: